Načítá se...
Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is among the most common human malignancies. METHODS: In order to provide better understanding of the molecular biology of ccRCC and to identify potential diagnostic/prognostic biomarker and therapeutic targets, we utilized a microarray to profile...
Uloženo v:
| Vydáno v: | Mol Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4736613/ https://ncbi.nlm.nih.gov/pubmed/26831905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-016-0495-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|